Twenty-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalized in Switzerland.
Mahendiran T., Hoepli A., Foster-Witassek F., Rickli H., Roffi M., Eberli F., Pedrazzini G., Jeger R., Radovanovic D., Fournier S. et al., 2023/10/10. European journal of preventive cardiology, 30 (14) pp. 1504-1512. Peer-reviewed.
Prise en charge cardio-oncologique : un nouveau défi pour le praticien [Cardio-oncological risk stratification and follow up: a new challenge for the general practitioner]
Prise en charge coordonnée de l’hypertension artérielle entre le praticien et les spécialistes - Place de la dénervation rénale dans l’HTA résistante [Coordinated management of arterial hypertension]
Influence des canicules sur l’incidence du syndrome de Takotsubo : étude rétrospective en Valais [The influence of summer temperatures on the incidence of Takotsubo cardiomyopathy : a retrospective study]
Duchatelle V., Delhasse S., Karpuz B., Alexe R., Tapponnier M., Sierro C., Girod G., 2022/02/23. Revue medicale suisse, 18 (770) pp. 343-346. Peer-reviewed.
Implementation of cascade genetic screening for familial hypercholesterolemia: Design of the Swiss catch randomized controlled trial
Nanchen D., Von Känel T., Brun N., Sudano I., Rickli H., Ehret G., Girod G., Del Giorno R., Rodondi N., Beer J.H. et al., 2021/08. pp. e184 dans EAS 2021 abstracts : European Atherosclerosis Society, Atherosclerosis.
Total Endovascular Repair of Post-Trauma Ascending Aortic Pseudoaneurysm and Secondary Superior Vena Cava Syndrome.
Colombier S., Girod G., Niclauss L., Danzer D., Eeckhout E., Qanadli S.D., Delay D., 2019/11. Annals of vascular surgery, 61 pp. 468.e13-468.e17. Peer-reviewed.
Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry.
Hunziker L., Radovanovic D., Jeger R., Pedrazzini G., Cuculi F., Urban P., Erne P., Rickli H., Pilgrim T., AMIS Plus Registry Investigators are listed in alphabetic order with the names of the local principal investigators, 2019/04. Circulation. Cardiovascular interventions, 12 (4) pp. e007293. Peer-reviewed.
Outcomes following implantation of the Biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registry.
Urban P., Valdés M., Menown I., Eberli F., Alhaddad I., Hildick-Smith D., Iosseliani D., Roffi M., Oldroyd K., Kalloudi E. et al., 2015/12/01. Catheterization and cardiovascular interventions, 86 (7) pp. 1151-1160. Peer-reviewed.
Inpatient versus outpatient onsets of acute myocardial infarction.
Erne P., Bertel O., Urban P., Pedrazzini G., Lüscher T.F., Radovanovic D., AMIS Plus Investigators, 2015/07. European journal of internal medicine, 26 (6) pp. 414-419.
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon C.P., Blazing M.A., Giugliano R.P., McCagg A., White J.A., Theroux P., Darius H., Lewis B.S., Ophuis T.O., Jukema J.W. et al., 2015/06/18. The New England journal of medicine, 372 (25) pp. 2387-2397.
Very long-term follow-up after percutaneous closure of patent foramen ovale.
Eeckhout E., Martin S., Delabays A., Michel P., Girod G., 2015. Eurointervention : Journal of Europcr In Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology, 10 (12) pp. 1474-1479. Peer-reviewed.
Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry.
Jeger R., Jaguszewski M., Nallamothu B.N., Lüscher T.F., Urban P., Pedrazzini G.B., Erne P., Radovanovic D., AMIS Plus Investigators, 2014. International Journal of Cardiology, 172 (1) pp. 76-81.
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.
Camenzind E., Boersma E., Wijns W., Mauri L., Rademaker-Havinga T., Ordoubadi F.F., Suttorp M.J., Al Kurdi M., Steg P.G., PROTECT Steering Committee et al., 2014. European Heart Journal, 35 (29) pp. 1932-1948.
Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012.
Radovanovic D., Seifert B., Urban P., Eberli F.R., Rickli H., Bertel O., Puhan M.A., Erne P., AMIS Plus Investigators, 2014. Heart, 100 (4) pp. 288-294.
Approche des valvutlopathies cardiaques par le praticien. Investigations diagnostiques et place du traitement médicamenteux [Practical approach of cardiac valvulopathies].
Fermeture percutanée de l'auricule gauche: un nouvel espoir pour le patient en fibrillation auriculaire [Percutaneous closure of left atrial appendage: a new hope for patients with atrial fibrillation?].
Girod G., Delabays A., Eeckhout E., Fromer M., Monney P., Vogt P., Pruvot E., 2013. Revue Médicale Suisse, 9 (372) pp. 332-336.
Quatité du traitement après infarctus du myocarde: impact de recommandations hospitalières [Quality of treatment after myocardial infarction: impact of hospital guidelines].
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.
Camenzind E., Wijns W., Mauri L., Kurowski V., Parikh K., Gao R., Bode C., Greenwood J.P., Boersma E., Vranckx P. et al., 2012. Lancet, 380 (9851) pp. 1396-1405.
Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation.
Camenzind E., Wijns W., Mauri L., Boersma E., Parikh K., Kurowski V., Gao R., Bode C., Greenwood J.P., Gershlick A. et al., 2009. American Heart Journal, 158 (6) pp. 902-909.e5.
Ombres et lumières de l'accès public a la défibrillation [Public access defibrillation]
Katz E., Metzger J.T., Sierro C., Deac M., Fishman D., Girod G., Potin M., Niquille M., Stauffer J.C., Kehtari R. et al., 2008. Revue Médicale Suisse, 4 (168) pp. 1836-40.
Echographie intracardiaque: un nouvel outil en cardiologie interventionnelle. [Intracardiac echocardiography: a new tool for interventional cardiology]
Girod G., Delabays A., Roguelov C., Renders F., Van de Walle S., Vogt P., Eckhout E., 2007/07. Revue Médicale Suisse, 3 (118) pp. 1696-701.
Bloc atrioventriculaire complet sur borréliose de Lyme: aspects etectrocardiographiques, diagnostiques et microbiologiques [Atrioventricular heart block in Lyme disease]
Pasquier M., Péter O., Frochaux V., Imsand C., Vogt P., Girod G., 2006. Revue Médicale Suisse, 2 (52) pp. 415-417.
Direct stenting with a combined intravascular ultrasound-coronary stent delivery platform: a feasibility trial
Eeckhout E., Berger A., Roguelov C., Lyon X., Imsand C., Fivaz-Arbane M., Girod G., De Benedetti E., 2003/08. Catheterization and Cardiovascular Interventions, 59 (4) pp. 451-4.
Hypertrophie ventriculaire gauche: un marqueur des patients a risque d'hypotension arterielle durant l'echocardiographie de stress sous dobutamine? [Left ventricular hypertrophy: a marker for patients at risk of arterial hypotension during stress echocardiography with dobutamine?]
Girod G., Jaussi A., Kappenberger L., 2003/06. Archives des Maladies du Coeur et des Vaisseaux, 96 (6) pp. 624-30.
Cavitation versus degassing: in vitro study of the microbubble phenomenon observed during echocardiography in patients with mechanical prosthetic cardiac valves
Girod G., Jaussi A., Rosset C., De Werra P., Hirt F., Kappenberger L., 2002/10. Echocardiography, 19 (7 Pt 1) pp. 531-6.
